Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $15.82 Analyst target: $15.17 Upside: -4.11%
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
See the full interactive analysis & chart →Informational only — not investment advice.